Skip to main content
FutureCore Co.,Ltd. logo

FutureCore Co.,Ltd. — Investor Relations & Filings

Ticker · 151910 ISIN · KR7151910007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 361 across all filing types
Latest filing 2022-12-19 Capital/Financing Update
Country KR South Korea
Listing KO 151910

About FutureCore Co.,Ltd.

http://futurecore.co.kr/en/home-e/

FutureCore Co., Ltd. is a company that develops, manufactures, and sells electrical and electronic components. The company specializes in the production of optical filters for imaging applications, particularly for phone and camera modules. Its main products include a variety of optical filters such as IR cutoff filters, blue filters, IR pass filters, and IR band filters. In addition to its filter products, the company also manufactures Hall sensors.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (SBW Life Science) regarding the 'acquisition of convertible bonds before maturity'. This falls under capital structure changes and financing activities. Since it specifically details the repurchase/acquisition of debt instruments (convertible bonds) by the company, it aligns best with the 'Capital/Financing Update' category.
2022-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice regarding the setting of a record date and shareholder register closure for the purpose of holding an Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory announcement of the upcoming meeting logistics. Given it is a standard regulatory notification that does not fit into specific categories like AGM-R (presentation) or PSI (proxy solicitation), it is classified as a general regulatory filing.
2022-12-16 Korean
전환가액의조정
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from SBW Life Science regarding the adjustment of the conversion price of convertible bonds due to a decline in market price. This type of disclosure, which details changes to capital structure instruments (convertible bonds), falls under the 'Capital/Financing Update' category as it directly impacts the company's equity dilution and financing terms.
2022-12-14 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Regulatory Filings Classification · 1% confidence The document is a formal response to a regulatory inquiry (조회공시요구) regarding market rumors about a potential acquisition, capital increase, and change in management control. It is a standard regulatory disclosure filed with the exchange to address market speculation. Since it does not fit into specific categories like M&A (which would be a definitive agreement) or Share Issue (which would be a confirmed event), it falls under the general regulatory filing category.
2022-11-21 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from SBW Life Science regarding the adjustment of the conversion price for convertible bonds due to a decline in market price. This type of disclosure relates to changes in capital structure and financing terms, which falls under the 'Capital/Financing Update' category.
2022-11-18 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for SBW Life Sciences Co., Ltd., covering the period from 2022.01.01 to 2022.09.30. It contains detailed corporate information, history, capital structure, and financial data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.